Shapiro Aron
SEC insider (Form 3/4/5 filer). CIK 0001855207. Director at KIORA PHARMACEUTICALS INC (KPRX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in ENCINITAS, CA.
Companies Shapiro Aron has filed insider reports for
- KIORA PHARMACEUTICALS INC (KPRX): Director
Shapiro Aron
CIK: 0001855207
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KPRX
KIORA PHARMACEUTICALS INC
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 10, 2026KPRX
KIORA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
25K shares- - Apr 1, 2025KPRX
KIORA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
20K shares- - Sep 10, 2024KPRX
KIORA PHARMACEUTICALS INC
PurchaseIndirect3K shares at avg. $3.60$11K
1-3 of 3 transactions